Association of Serum MicroRNA-145-5p Levels with Microvascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study

Federica Barutta; Stefania Bellini; Simonetta Guarrera; Giuseppe Matullo; Casper Schalkwijk; Coen D Stehouwer; Nish Chaturvedi; Sabita S Soedamah-Muthu; Marilena Durazzo; Gabriella Gruden

doi:10.1016/j.diabres.2022.109987

Association of Serum MicroRNA-145-5p Levels with Microvascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study

Federica Barutta^*, Stefania Bellini, Simonetta Guarrera, Giuseppe Matullo, Casper Schalkwijk, Coen D Stehouwer, Nish Chaturvedi, Sabita S Soedamah-Muthu, Marilena Durazzo, Gabriella Gruden

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

AIMS: To investigate whether serum miR-145-5p levels were associated with micro-macrovascular chronic complications in patients with type 1 diabetes (DM1).

METHODS: A nested case-control study from the EURODIAB Prospective Complications Study was performed. Cases (n=289) had one or more complications of diabetes, whereas controls (n=153) did not have any complication. We measured miR-145-5p levels by qPCR and investigated the association with diabetes complications.

RESULTS: Mean miR-145-5p levels were significantly lower in cases with microangiopathy [2.12 (0.86-4.94)] compared to controls [3.15 (1.21-7.36), P<0.05] even after adjustment for age, gender, and diabetes duration. In logistic regression analysis, miR-145-5p levels in the lowest tertile were associated with an over three-fold increased odds ratio (OR) of albuminuria [3.22 (1.17-8.81)], independently of both demographic and diabetes-related factors. In addition, mir145-5p levels in the lowest tertile were independently and inversely associated with arterial hypertension [1.96 (1.08-3.56)] and hypertension was the mediator of the relationship between miR-145-5p and albuminuria.

CONCLUSIONS: In this large cohort of DM1 patients, we found an inverse association between miR-145-5p and albuminuria that was mediated by systemic hypertension.

Original language	English
Article number	109987
Number of pages	8
Journal	Diabetes Research and Clinical Practice
Volume	190
Early online date	9 Jul 2022
DOIs	https://doi.org/10.1016/j.diabres.2022.109987
Publication status	Published - Aug 2022

Keywords

Albuminuria
BIOMARKERS
CARDIOVASCULAR-DISEASE
CIRCULATING MICRORNAS
Cardiovascular diseases
Diabetic complications
Diabetic kidney disease
Diabetic nephropathy
EXPRESSION
Hypertension
MARKERS
MECHANISMS
MIRNAS
RETINOPATHY
SMOOTH-MUSCLE-CELLS
TARGETS
TGF-beta 1
Type 1 diabetes
microRNAs

Access to Document

10.1016/j.diabres.2022.109987Licence: CC BY-NC-ND

Cite this

Barutta, F., Bellini, S., Guarrera, S., Matullo, G., Schalkwijk, C., Stehouwer, C. D., Chaturvedi, N., Soedamah-Muthu, S. S., Durazzo, M., & Gruden, G. (2022). Association of Serum MicroRNA-145-5p Levels with Microvascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study. Diabetes Research and Clinical Practice, 190, Article 109987. https://doi.org/10.1016/j.diabres.2022.109987

@article{fe13c94c8a12426cad6a48d1e38b203b,

title = "Association of Serum MicroRNA-145-5p Levels with Microvascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study",

abstract = "AIMS: To investigate whether serum miR-145-5p levels were associated with micro-macrovascular chronic complications in patients with type 1 diabetes (DM1).METHODS: A nested case-control study from the EURODIAB Prospective Complications Study was performed. Cases (n=289) had one or more complications of diabetes, whereas controls (n=153) did not have any complication. We measured miR-145-5p levels by qPCR and investigated the association with diabetes complications.RESULTS: Mean miR-145-5p levels were significantly lower in cases with microangiopathy [2.12 (0.86-4.94)] compared to controls [3.15 (1.21-7.36), P<0.05] even after adjustment for age, gender, and diabetes duration. In logistic regression analysis, miR-145-5p levels in the lowest tertile were associated with an over three-fold increased odds ratio (OR) of albuminuria [3.22 (1.17-8.81)], independently of both demographic and diabetes-related factors. In addition, mir145-5p levels in the lowest tertile were independently and inversely associated with arterial hypertension [1.96 (1.08-3.56)] and hypertension was the mediator of the relationship between miR-145-5p and albuminuria.CONCLUSIONS: In this large cohort of DM1 patients, we found an inverse association between miR-145-5p and albuminuria that was mediated by systemic hypertension.",

keywords = "Albuminuria, BIOMARKERS, CARDIOVASCULAR-DISEASE, CIRCULATING MICRORNAS, Cardiovascular diseases, Diabetic complications, Diabetic kidney disease, Diabetic nephropathy, EXPRESSION, Hypertension, MARKERS, MECHANISMS, MIRNAS, RETINOPATHY, SMOOTH-MUSCLE-CELLS, TARGETS, TGF-beta 1, Type 1 diabetes, microRNAs",

author = "Federica Barutta and Stefania Bellini and Simonetta Guarrera and Giuseppe Matullo and Casper Schalkwijk and Stehouwer, {Coen D} and Nish Chaturvedi and Soedamah-Muthu, {Sabita S} and Marilena Durazzo and Gabriella Gruden",

note = "Copyright {\textcopyright} 2022. Published by Elsevier B.V.",

year = "2022",

month = aug,

doi = "10.1016/j.diabres.2022.109987",

language = "English",

volume = "190",

journal = "Diabetes Research and Clinical Practice",

issn = "0168-8227",

publisher = "Elsevier Ireland Ltd",

}

Barutta, F, Bellini, S, Guarrera, S, Matullo, G, Schalkwijk, C, Stehouwer, CD, Chaturvedi, N, Soedamah-Muthu, SS, Durazzo, M & Gruden, G 2022, 'Association of Serum MicroRNA-145-5p Levels with Microvascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study', Diabetes Research and Clinical Practice, vol. 190, 109987. https://doi.org/10.1016/j.diabres.2022.109987

TY - JOUR

T1 - Association of Serum MicroRNA-145-5p Levels with Microvascular Complications of Type 1 Diabetes

T2 - the EURODIAB Prospective Complications Study

AU - Barutta, Federica

AU - Bellini, Stefania

AU - Guarrera, Simonetta

AU - Matullo, Giuseppe

AU - Schalkwijk, Casper

AU - Stehouwer, Coen D

AU - Chaturvedi, Nish

AU - Soedamah-Muthu, Sabita S

AU - Durazzo, Marilena

AU - Gruden, Gabriella

PY - 2022/8

Y1 - 2022/8

N2 - AIMS: To investigate whether serum miR-145-5p levels were associated with micro-macrovascular chronic complications in patients with type 1 diabetes (DM1).METHODS: A nested case-control study from the EURODIAB Prospective Complications Study was performed. Cases (n=289) had one or more complications of diabetes, whereas controls (n=153) did not have any complication. We measured miR-145-5p levels by qPCR and investigated the association with diabetes complications.RESULTS: Mean miR-145-5p levels were significantly lower in cases with microangiopathy [2.12 (0.86-4.94)] compared to controls [3.15 (1.21-7.36), P<0.05] even after adjustment for age, gender, and diabetes duration. In logistic regression analysis, miR-145-5p levels in the lowest tertile were associated with an over three-fold increased odds ratio (OR) of albuminuria [3.22 (1.17-8.81)], independently of both demographic and diabetes-related factors. In addition, mir145-5p levels in the lowest tertile were independently and inversely associated with arterial hypertension [1.96 (1.08-3.56)] and hypertension was the mediator of the relationship between miR-145-5p and albuminuria.CONCLUSIONS: In this large cohort of DM1 patients, we found an inverse association between miR-145-5p and albuminuria that was mediated by systemic hypertension.

AB - AIMS: To investigate whether serum miR-145-5p levels were associated with micro-macrovascular chronic complications in patients with type 1 diabetes (DM1).METHODS: A nested case-control study from the EURODIAB Prospective Complications Study was performed. Cases (n=289) had one or more complications of diabetes, whereas controls (n=153) did not have any complication. We measured miR-145-5p levels by qPCR and investigated the association with diabetes complications.RESULTS: Mean miR-145-5p levels were significantly lower in cases with microangiopathy [2.12 (0.86-4.94)] compared to controls [3.15 (1.21-7.36), P<0.05] even after adjustment for age, gender, and diabetes duration. In logistic regression analysis, miR-145-5p levels in the lowest tertile were associated with an over three-fold increased odds ratio (OR) of albuminuria [3.22 (1.17-8.81)], independently of both demographic and diabetes-related factors. In addition, mir145-5p levels in the lowest tertile were independently and inversely associated with arterial hypertension [1.96 (1.08-3.56)] and hypertension was the mediator of the relationship between miR-145-5p and albuminuria.CONCLUSIONS: In this large cohort of DM1 patients, we found an inverse association between miR-145-5p and albuminuria that was mediated by systemic hypertension.

KW - Albuminuria

KW - BIOMARKERS

KW - CARDIOVASCULAR-DISEASE

KW - CIRCULATING MICRORNAS

KW - Cardiovascular diseases

KW - Diabetic complications

KW - Diabetic kidney disease

KW - Diabetic nephropathy

KW - EXPRESSION

KW - Hypertension

KW - MARKERS

KW - MECHANISMS

KW - MIRNAS

KW - RETINOPATHY

KW - SMOOTH-MUSCLE-CELLS

KW - TARGETS

KW - TGF-beta 1

KW - Type 1 diabetes

KW - microRNAs

U2 - 10.1016/j.diabres.2022.109987

DO - 10.1016/j.diabres.2022.109987

M3 - Article

C2 - 35820565

SN - 0168-8227

VL - 190

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

M1 - 109987

ER -

Association of Serum MicroRNA-145-5p Levels with Microvascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study

Abstract

Keywords

Access to Document

Fingerprint

Cite this